Edit Module

FDA To Evaluate Salmonella Risk



Published:

The Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM) is looking for participants in a cooperative agreement to enhance the center’s ability to evaluate Salmonella-contaminated feed risk on human and animal health.

CVM is seeking applications that will provide information on the prevalence of Salmonella in fecal samples from symptomatic and asymptomatic dogs and cats brought to veterinary clinics to gain further insight into the frequency of Salmonella infected animals following feed contamination.

The cooperative agreements will be with CVM’s Veterinary Laboratory Response Network (Vet-LRN), a program that coordinates facilities, equipment and professional expertise of U.S. and Canadian government and veterinary diagnostic laboratories.

Eligibility requirements to apply for a Vet-LRN agreement are demonstrating an adequate veterinary case load at the institution, technical expertise and ability to conduct the appropriate volume of cultures. Applicants will be evaluated as to their accreditation status and geographical location to provide program balance and a diverse patient population. The deadline for submission of applications is Aug. 15.

Cooperative agreements will be available for up to $60,000 in total costs for a year, with the possibility of a second year of funding.

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Dog Noses as a Diagnostic Copilot?

While dogs might not be part of diagnostic tools, their ability to detect cancer can help doctors do the same.

WSU Vet Establishes Veterinary Laparoscopic Training Program

The Veterinary Assessment Laparoscopic Skills (VALS) training program, created by Boel Fransson, DVM, provides training and certification for interested board-certified veterinary surgeons.

OSU, Blue Buffalo Mark First Clinical Trials Office Anniversary

"Our relationship with Ohio State is consistent with Blue Buffalo's philosophy of giving back and supporting studies that advance veterinary medicine," said Bill Bishop, company founder and chairman.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module